This article will look at the symptoms, risk factors, and complications of psoriatic arthritis
50 Next-Generation Modalities: Small Molecules and Poly-Agonists As the patent cliffs for current GLP-1 peptides approach, the industry is racing to develop next-generation assets that can achieve higher efficacy, better adherence, and refreshed IP protection
The key principle is to reduce slowly and monitor continuously, treating any upward weight trend as a signal to pause the reduction or increase one step
Arterioscler Thromb Vasc Biol 2013;33:22522260
Stated by Lilly: Q1 2027 (announced July 23, 2026, superseding the "submit in 2026" guidance given on the Q4 2025 earnings call, February 4, 2026)
These contrasting findings might be explained by substantial differences in study design, sample, and reward phase